![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
PARP Inhibitor Trial Updates (OncLive) View |
![]() |
PARP Inhibitors: 2023 Updates (OCRA) View |
![]() |
Update on PETRA trial investigating a next-generation PARP1 select inhibitor (VJOncology) View |
![]() |
Susan M. Domchek, MD: PARP Inhibitor Clinical Trials Update at AACR 2012 (Vital Options International) View |
![]() |
Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer (HMP Education) View |
![]() |
Case 3: Benefit of PARP Inhibitor Maintenance in Ovarian Cancer (Targeted Oncology) View |
![]() |
Updates in PARP Inhibition and Germline Testing in Prostate Cancer (Grand Rounds in Urology) View |
![]() |
Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer (ecancer) View |
![]() |
PARP Inhibitors and Ovarian Cancer | Memorial Sloan Kettering (Memorial Sloan Kettering Cancer Center) View |
![]() |
ESMO 2019: Dr. Mirza on Important Trials with PARP Inhibitors in Ovarian Cancer (OncLive) View |